iRhythm Technologies (IRTC) Investors: JP Morgan Reaffirms “Overweight” Rating, Sees $67/Share; Tootsie Roll Industries (TR) Shorts Down By 1.03%

February 15, 2018 - By Ellis Scott

Among 5 analysts covering iRhythm (IRTC), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. iRhythm has $79 highest and $28.0 lowest target. $70.67’s average target is 20.72% above currents $58.54 stock price. iRhythm had 13 analyst reports since November 14, 2016 according to SRatingsIntel. The stock of iRhythm Technologies, Inc. (NASDAQ:IRTC) earned “Overweight” rating by Morgan Stanley on Friday, November 3. Canaccord Genuity maintained it with “Buy” rating and $55 target in Friday, September 22 report. The firm earned “Buy” rating on Tuesday, June 6 by Canaccord Genuity. The firm earned “Overweight” rating on Monday, November 14 by JP Morgan. BTIG Research maintained iRhythm Technologies, Inc. (NASDAQ:IRTC) on Tuesday, July 11 with “Hold” rating. The company was maintained on Thursday, August 3 by Canaccord Genuity. The firm has “Buy” rating given on Tuesday, November 14 by Canaccord Genuity. On Thursday, November 2 the stock rating was maintained by Canaccord Genuity with “Buy”. Canaccord Genuity maintained iRhythm Technologies, Inc. (NASDAQ:IRTC) rating on Monday, October 23. Canaccord Genuity has “Buy” rating and $55.0 target. BTIG Research downgraded the stock to “Neutral” rating in Tuesday, December 6 report.

Tootsie Roll Industries Incorporated (NYSE:TR) had a decrease of 1.03% in short interest. TR’s SI was 4.41 million shares in February as released by FINRA. Its down 1.03% from 4.46 million shares previously. With 81,300 avg volume, 54 days are for Tootsie Roll Industries Incorporated (NYSE:TR)’s short sellers to cover TR’s short positions. The SI to Tootsie Roll Industries Incorporated’s float is 20.19%. The stock increased 0.73% or $0.25 during the last trading session, reaching $34.6. About 11,253 shares traded. Tootsie Roll Industries, Inc. (NYSE:TR) has risen 4.65% since February 15, 2017 and is uptrending. It has underperformed by 12.05% the S&P500.




The stock decreased 1.91% or $1.14 during the last trading session, reaching $58.54. About 192,606 shares traded. iRhythm Technologies, Inc. (IRTC) has 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Analysts await iRhythm Technologies, Inc. (NASDAQ:IRTC) to report earnings on February, 21. They expect $-0.35 earnings per share, up 5.41% or $0.02 from last year’s $-0.37 per share. After $-0.29 actual earnings per share reported by iRhythm Technologies, Inc. for the previous quarter, Wall Street now forecasts 20.69% negative EPS growth.

iRhythm Technologies, Inc., a digital healthcare company, focuses on the provision of ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias in the United States. The company has market cap of $1.35 billion. It offers ZIO Service, a platform that provides wearable biosensor with cloud data analytics that distill data from heartbeats into clinically actionable information. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: